Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.

Ampreloxetine, an investigational, once-daily norepinephrine reuptake inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple ...

Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment of major depressive disorder (MDD) and diabetic ...

In September 2024, the Company presented multiple data analyses at Sleep Europe 2024, including results from the SYMPHONY ...

The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...

When I lost weight on WW, I devoted all of my time to the program and I was successful. It was when life got hard that the ...

The researchers also recorded patients’ heart rate variability, injection pain level, Modified Observer’s Assessment of Alertness and Sedation score, body movement, number of norepinephrine doses ...

In patients receiving serotonergic medications in combination with an MAOI, there have been reports of serious and sometimes fatal reactions, including hyperthermia, rigidity, myoclonus, autonomic ...

Today, doctors have many alternative medication choices with little or no addictive potential. The treatment of choice for ...

Researchers linked four pollutive particles found in the air to a higher incidence of autism in people with a genetic predisposition disease.

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor behind depression, reshaping traditional views of the condition.